Harvard Bioscience (HBIO) EBITDA (2009 - 2026)
Harvard Bioscience (HBIO) reported EBITDA of $397,000 for Q2 2026, down 50.2% from $797,000 a year earlier but up 125.6% from the prior quarter.
Powered by 
Analysis
Harvard Bioscience (HBIO) EBITDA (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Harvard Bioscience's EBITDA came in at $5.15 million; for FY2025, it came in at -$42.64 million.
- By year, EBITDA came in at $946,000 in FY2024 (-89.4%), $8.92 million in FY2023, $642,000 in FY2022 (-93.4%) and $9.69 million in FY2021 (+23.4%).
- Five-year quarterly EBITDA spans a low of -$48.01 million in Q1 2025 and a high of $5.83 million in Q2 2022.
- The high point for year-over-year EBITDA in five years was Q2 2022 (growth of 196.0%); the low point was Q4 2022 (a decline of 58.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $176,000 (Q1 2026), $3.06 million (Q4 2025) and $1.52 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 266.22 Bn | 242.86 Bn | 5.13 Bn | 3.09 Bn |
| 2 | Abbott Laboratories | 191.31 Bn | 165.77 Bn | 7.39 Bn | 2.61 Bn |
| 3 | Danaher | 166.16 Bn | 145.82 Bn | 3.84 Bn | 1.97 Bn |
| 4 | Intuitive Surgical | 155.98 Bn | 136.40 Bn | 2.08 Bn | 789.70 Mn |
| 5 | Medtronic | 130.05 Bn | 96.18 Bn | 6.34 Bn | 2.49 Bn |
| 6 | Stryker | 123.40 Bn | 109.59 Bn | 4.25 Bn | - |
| 7 | Boston Scientific | 64.81 Bn | 60.48 Bn | 3.43 Bn | 1.19 Bn |
| 8 | Edwards Lifesciences | 59.87 Bn | 43.18 Bn | 1.35 Bn | 344.00 Mn |
| 9 | Medline | 53.84 Bn | 50.96 Bn | 1.93 Bn | 769.00 Mn |
| 10 | Harvard Bioscience | 42.35 Mn | 15.23 Mn | 12.31 Mn | 274,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 274,000.00 |
| Jun 30, 2026 | 894,000.00 |
| Mar 31, 2026 | 622,000.00 |
| Dec 31, 2025 | 3.68 Mn |
| Sep 30, 2025 | 1.88 Mn |
| Jun 30, 2025 | 1.01 Mn |
| Mar 31, 2025 | -47.88 Mn |
| Dec 31, 2024 | 1.87 Mn |
| Sep 30, 2024 | 30,000.00 |
| Jun 30, 2024 | -198,000.00 |
| Mar 31, 2024 | -428,000.00 |
| Dec 31, 2023 | 2.16 Mn |
| Sep 30, 2023 | 916,000.00 |
| Jun 30, 2023 | 2.59 Mn |
| Mar 31, 2023 | 3.54 Mn |
| Dec 31, 2022 | 1.57 Mn |
| Sep 30, 2022 | -1.76 Mn |
| Jun 30, 2022 | 5.90 Mn |
| Mar 31, 2022 | -4.79 Mn |
| Dec 31, 2021 | 3.69 Mn |
API Access
Harvard Bioscience EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=HBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "HBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=HBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();